Please provide your email address to receive an email when new articles are posted on . ADR in standard colonoscopy dropped significantly from 28.4% before AI exposure to 22.4% after. Results suggest ...

The benefits of artificial intelligence (AI) in the medical space are ever-growing, but evidence suggests it can also come with risks. A new study by European researchers investigated how AI can ...

Colonoscopy performed with an artificial intelligence (AI)–based computer-aided detection (CADe) system decreased the adenoma miss rate (AMR) by roughly half in comparison to standard colonoscopy ...

Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that ColonPRO EU, the Company’s next-generation artificial intelligence software ...

"Our results are concerning given the adoption of AI in medicine is rapidly spreading." HealthDay News — Exposure to artificial intelligence (AI)-assisted colonoscopy is associated with a reduction in ...

In a new study, artificial intelligence matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn's disease patients.

Artificial intelligence (AI) refers to a computer system capable of simulating human learning, understanding, problem-solving ...

Colorectal cancer is increasingly affecting younger adults, with a notable rise in cases among those under 50.

The latest announcement is out from COSMO Pharmaceuticals N.V. ( ($CH:COPN) ). Cosmo Pharmaceuticals N.V. has received CE certification for its ...

In patients with type 2 diabetes, GLP-1 receptor agonists were associated with a higher risk for gastroesophageal reflux disease (GERD) compared with SGLT-2 inhibitors. (Annals of Internal Medicine) A ...